Purdue Pharma LP’s pain therapy Butrans (buprenorphine) has new pediatric labeling – but no specific information about the pediatric study itself.
On Oct. 13, the US FDA “approved” a supplement filed by Purdue seeking to include a description of a pediatric...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?